Expertise in
15
conditions

Dr. Shanker N. Dixit

Neurology
Shanker Dixit, MD PC
2480 Professional Ct, 
Las Vegas, NV 
Accepting New Patients
Expertise in
15
conditions
Shanker Dixit, MD PC
2480 Professional Ct, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Shanker Dixit is a Neurologist in Las Vegas, Nevada. Dr. Dixit is highly rated in 15 conditions, according to our data. His top areas of expertise are Microcephaly, Microcephaly with Spastic Quadriplegia, Zika Virus Disease, and Seizures. Dr. Dixit is currently accepting new patients.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in WI
Languages Spoken
English
Hindi
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

SHANKER DIXIT, MD PC
2480 Professional Ct, Las Vegas, NV 89128

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
Enrollment Status: Completed
Publish Date: April 29, 2025
Intervention Type: Drug
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in Restless Legs Syndrome Patients With Iron-deficiency Anemia
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in Restless Legs Syndrome Patients With Iron-deficiency Anemia
Enrollment Status: Terminated
Publish Date: April 11, 2025
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 2
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
21
conditions
Dr. Zoltan K. Mari
Neurology
Expertise in
21
conditions
Dr. Zoltan K. Mari
Neurology

Cleveland Clinic Nevada

888 W Bonneville Ave, 
Las Vegas, NV 
 (6.1 mi)
702-483-6000
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Zoltan Mari is a Neurologist in Las Vegas, Nevada. Dr. Mari is highly rated in 21 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Focal Dystonia, and Deep Brain Stimulation. Dr. Mari is currently accepting new patients.

Expertise in
8
conditions
Dr. Jiong T. Shi
Neurology
Expertise in
8
conditions
Dr. Jiong T. Shi
Neurology
888 W Bonneville Ave, 
Las Vegas, NV 
 (6.1 mi)
702-483-6000
Languages Spoken:
English

Jiong Shi is a Neurologist in Las Vegas, Nevada. Dr. Shi is highly rated in 8 conditions, according to our data. Their top areas of expertise are Normal Pressure Hydrocephalus, Hydrocephalus, Congenital Cardiovascular Shunt, and Alzheimer's Disease.

Expertise in
18
conditions
Dr. Odinachi N. Oguh
Neurology
Expertise in
18
conditions
Dr. Odinachi N. Oguh
Neurology

Cleveland Clinic Nevada

888 W Bonneville Ave, 
Las Vegas, NV 
 (6.1 mi)
702-483-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Odinachi Oguh is a Neurologist in Las Vegas, Nevada. Dr. Oguh is highly rated in 18 conditions, according to our data. Their top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Torticollis. Dr. Oguh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dixit's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 34 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile